Freestone Grove Partners LP Staar Surgical CO Call Options Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STAA
# of Institutions
233Shares Held
47.7MCall Options Held
98.6KPut Options Held
180K-
Broadwood Capital Inc New York, NY10.8MShares$183 Million20.84% of portfolio
-
Black Rock Inc. New York, NY7.49MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$98.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.05MShares$34.6 Million0.0% of portfolio
-
Resona Asset Management Co.,Ltd. Koto Ku,Tokyo, M01.5MShares$25.3 Million0.22% of portfolio
About STAAR SURGICAL CO
- Ticker STAA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 48,038,300
- Market Cap $809M
- Description
- STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...